SCHEMBL31661779

SCHEMBL31661779

O=C(O)CCCCCCCNC(=O)c1cc2ccccc2oc1=O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
MAOB P27338 6/20 0.67
AKR1B10 O60218 1/20 0.65
KDM4E B2RXH2 6/20 0.63
ALDH1A1 P00352 5/20 0.63
HSD17B10 Q99714 5/20 0.63
KMT2A Q03164 2/20 0.62
MEN1 O00255 1/20 0.62
MAPK1 P28482 1/20 0.62
HTT P42858 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
MAOA P21397 2/20 0.61
HPGD P15428 1/20 0.61
TSHR P16473 1/20 0.61
LMNA P02545 1/20 0.60
THRB P10828 1/20 0.60
F12 P00748 1/20 0.57
BCHE P06276 2/20 0.57
ACHE P22303 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5655976 1.00 NPC1 (0.68) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL34468836 0.86 KDM4E (0.71) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL7511318 0.84 KDM4E (0.73) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL3040430 0.82 MAOB (0.73) NPC1L3MBTL1MAOBKDM4EALDH1A1
SCHEMBL34468932 0.81 NPC1 (1.00) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL15892984 0.81 MAOB (1.00) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL14346006 0.81 MAOB (0.76) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL76133 0.80 MAOB (0.75) NPC1L3MBTL1MAOBKDM4EALDH1A1
SCHEMBL24023115 0.80 AKR1B10 (0.48) NPC1L3MBTL1MAOBAKR1B10KDM4E
SCHEMBL5339316 0.80 AKR1B10 (0.48) NPC1L3MBTL1AKR1B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed